Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Cash Flow from Operations

Acadia Pharmaceutica Cash Flow from Operations Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Acadia Pharmaceutica Cash Flow from Operations for the quarter ending June 06, 2020 was $-37m a 48.89% decrease of -18m year over year
  • Acadia Pharmaceutica Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-134m a -19.38% increase of 26m year over year
  • Acadia Pharmaceutica Annual Cash Flow from Operations for 2019 was $-151m a -10.81% increase of 16m from 2018
  • Acadia Pharmaceutica Annual Cash Flow from Operations for 2018 was $-167m a -30.03% increase of 50m from 2017
  • Acadia Pharmaceutica Annual Cash Flow from Operations for 2017 was $-218m a 4.29% decrease of -9m from 2016
Other Cash Flow Metrics:
  • Acadia Pharmaceutica Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-22m a 80.38% decrease of -17m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Cash Flow from Operations Data

06/2020$-37m
03/2020$-49m
12/2019$-30m
09/2019$-19m
06/2019$-38m
03/2019$-64m
12/2018$-39m
09/2018$-42m
06/2018$-41m
03/2018$-45m

Annual ACAD Cash Flow from Operations Data

2019$-151m
2018$-167m
2017$-218m
2016$-208m
2015$-122m
2014$-66m
2013$-32m
2012$-22m
2011$-20m
2010$-11m